CLINICAL_TRIALS
trial_result
· 2019-03-12
Clinical Trial Update: Dose-finding Study of APD403 to Prevent Nausea and Vomiting After Chemotherapy [Phase 2]
Summary
Phase 2 dose-finding study of APD403 for prevention of nausea and vomiting after chemotherapy has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Acacia Pharma Ltd | Conditions: CINV | Phase 2 | Status: COMPLETED | Results posted: 2019-03-12